Insulin Protein (INS)
-
- Antigène Voir toutes Insulin (INS) Protéines
- Insulin (INS)
- Type de proteíne
- Recombinant
-
Origine
- Humain
-
Source
- Levure
- Application
- Western Blotting (WB), ELISA
- Pureté
- Greater than 95 % by SDS-PAGE gel analyses
- Stérilité
- 0.2 μm filtered
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/mL in sterile distilled water by gentle pipetting 2-3 times, don't vortex
- Buffer
- Lyophilized from a 0.2 μm filtered solution in 10 mM Hepes, 500 mM NaCl with 5 % trehalose and 0.06 % proclin, pH 7.4
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- -20°C for 12 months as lyophilized, 2-8°C for 1 month under sterile conditions after reconstitution
- Date de péremption
- 12 months
-
- Antigène
- Insulin (INS)
- Autre désignation
- Insulin (INS Produits)
- Sujet
- IDDM,IDDM1,IDDM2,ILPR,ins,INS_HUMAN,Insulin A chain,Insulin B chain,IRDN,MODY10,Preproinsulin,Proinsulin,Proinsulin precursor
- Poids moléculaire
- 5.8 kDa
- UniProt
- P01308
- Pathways
- Signalisation NF-kappaB, Signalisation RTK, Positive Regulation of Peptide Hormone Secretion, Peptide Hormone Metabolism, Hormone Activity, Carbohydrate Homeostasis, ER-Nucleus Signaling, Regulation of Carbohydrate Metabolic Process, Feeding Behaviour, Autophagy, Negative Regulation of intrinsic apoptotic Signaling, Brown Fat Cell Differentiation, Positive Regulation of fat Cell Differentiation
-